https://insightsemerge.com/press-releases/compugen-reports-third-quarter-2026-resultsInsights Emergeen2026-11-09T12:23:11.021ZCompugen Reports Third Quarter 2026 Results https://insightsemerge.com/press-releases/johnson-and-johnson-announces-icotyder-icotrokinra-delivers-significant-improvement-inInsights Emergeen2026-11-07T15:18:46.079ZJohnson & Johnson announces ICOTYDE® (icotrokinra) delivers significant improvement in psoriatic arthritis disease activity among biologic-naive patients with once-daily targeted oral peptide